GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vivo Bio Tech Ltd (BOM:511509) » Definitions » Price-to-Owner-Earnings

Vivo Bio Tech (BOM:511509) Price-to-Owner-Earnings : (As of Jun. 10, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Vivo Bio Tech Price-to-Owner-Earnings?

As of today (2024-06-10), Vivo Bio Tech's share price is ₹40.22. Vivo Bio Tech does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Vivo Bio Tech's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Vivo Bio Tech was 28.72. The lowest was 6.05. And the median was 8.45.


BOM:511509's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 34.2
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-10), Vivo Bio Tech's share price is ₹40.22. Vivo Bio Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹1.52. Therefore, Vivo Bio Tech's PE Ratio for today is 26.46.

As of today (2024-06-10), Vivo Bio Tech's share price is ₹40.22. Vivo Bio Tech's EPS without NRI for the trailing twelve months (TTM) ended in was ₹1.52. Therefore, Vivo Bio Tech's PE Ratio without NRI for today is 26.46.

During the past 13 years, Vivo Bio Tech's highest PE Ratio without NRI was 136.92. The lowest was 2.73. And the median was 21.03.


Vivo Bio Tech Price-to-Owner-Earnings Historical Data

The historical data trend for Vivo Bio Tech's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivo Bio Tech Price-to-Owner-Earnings Chart

Vivo Bio Tech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.70 14.79 - - -

Vivo Bio Tech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vivo Bio Tech's Price-to-Owner-Earnings

For the Biotechnology subindustry, Vivo Bio Tech's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivo Bio Tech's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vivo Bio Tech's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vivo Bio Tech's Price-to-Owner-Earnings falls into.



Vivo Bio Tech Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vivo Bio Tech's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=40.22/-5.81
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivo Bio Tech  (BOM:511509) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vivo Bio Tech Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vivo Bio Tech's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivo Bio Tech (BOM:511509) Business Description

Traded in Other Exchanges
N/A
Address
Number 8-2-672/ 5 and 6, Road Number 1, 3rd Floor, Ilyas Mohammed Khan Estate, Banjara hills, Hyderabad, TG, IND, 500034
Vivo Bio Tech Ltd offers drug development and discovery services to pharmaceutical and biotech companies. The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies. It offers services in the areas of pharmacology, toxicology, pathology, analytical chemistry, lab animal diagnostics, custom model generation, custom breeding, surgical models, and molecular biology.

Vivo Bio Tech (BOM:511509) Headlines

No Headlines